These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 6338896)

  • 41. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers.
    Knowles DM; Halper JP; Azzo W; Wang CY
    Cancer; 1983 Oct; 52(8):1369-77. PubMed ID: 6193856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T lymphomas associated with human T-cell leukemia-lymphoma virus may show phenotypic and functional differences from adult T-cell leukemias.
    Yamada Y; Amagasaki T; Kamihira S; Kinoshita K; Ikeda S; Kusano M; Suzuyama J; Toriya K; Tomonaga Y; Ichimaru M
    Clin Immunol Immunopathol; 1985 Sep; 36(3):306-19. PubMed ID: 2990783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.
    Pallesen G; Beverley PC; Lane EB; Madsen M; Mason DY; Stein H
    J Clin Pathol; 1984 Aug; 37(8):911-8. PubMed ID: 6381546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas.
    Stein H; Bonk A; Tolksdorf G; Lennert K; Rodt H; Gerdes J
    J Histochem Cytochem; 1980 Aug; 28(8):746-60. PubMed ID: 7003001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.
    Burns BF; Warnke RA; Doggett RS; Rouse RV
    Am J Pathol; 1983 Nov; 113(2):165-71. PubMed ID: 6605688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell surface marker studies in a patient with cutaneous multilobated T-cell lymphoma.
    Fattorossi A; Moretti S; Palermo A; Santucci M; Bondi R; Giannotti B
    Br J Dermatol; 1985 Nov; 113(5):587-96. PubMed ID: 3904811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
    Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
    Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
    Lauder I; Bird CC; Child JA; Grigor I
    J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mantle-zone lymphoma. A pattern produced by lymphomas of more than one cell type.
    Harris NL; Bhan AK
    Am J Surg Pathol; 1985 Dec; 9(12):872-82. PubMed ID: 2933967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue.
    Linder J; Ye YL; Harrington DS; Armitage JO; Weisenburger DD
    Am J Pathol; 1987 Apr; 127(1):1-8. PubMed ID: 3494405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
    Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
    Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphocyte subsets in normal human lymphoid tissues.
    Hsu SM; Cossman J; Jaffe ES
    Am J Clin Pathol; 1983 Jul; 80(1):21-30. PubMed ID: 6190394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-surface-marker phenotyping in patients with leukemic non-Hodgkin lymphomas (NHL) of low and intermediate malignancy.
    Herrmann F; Wirthmüller R
    Immunobiology; 1982 Oct; 163(1):77-94. PubMed ID: 7173978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deficiency of mature B and T lymphocyte subsets in the blood of non-Hodgkin lymphoma patients.
    Janowska-Wieczorek A; Andrews EJ; Khaliq A; Pilarski LM
    Am J Hematol; 1987 Oct; 26(2):125-34. PubMed ID: 3499070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
    Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
    Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.
    Weiss LM; Crabtree GS; Rouse RV; Warnke RA
    Am J Pathol; 1985 Feb; 118(2):316-24. PubMed ID: 3155915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double immunoenzymatic detection of surface phenotype of proliferating lymphocytes in situ with monoclonal antibodies against DNA polymerase alpha and lymphocyte membrane antigens.
    Namikawa R; Ueda R; Suchi T; Itoh G; Ota K; Takahashi T
    Am J Clin Pathol; 1987 Jun; 87(6):725-31. PubMed ID: 2438927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The immunoarchitecture of cutaneous pseudolymphoma.
    Wirt DP; Grogan TM; Jolley CS; Rangel CS; Payne CM; Hansen RC; Lynch PJ; Schuchardt M
    Hum Pathol; 1985 May; 16(5):492-510. PubMed ID: 3157635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.